Article
Reduced Expression of SMAD4 Is Associated with Poor Survival in Colon Cancer
9 Feb 2016
Abstract excerpt
PURPOSE: SMAD4 loss is associated with the development of metastases and poor prognosis. We evaluated expression of SMAD4 protein and its association with tumor characteristics, including biomarkers and outcome in terms of relapse-free survival and overall survival. EXPERIMENTAL DESIGN: We used 1,564 stage II/III colon cancer samples from PETACC-3 to evaluate SMAD4 expression by immunohistochemistry. SMAD4...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
